Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states?
Publication
, Journal Article
Crowley, M; Powers; Myers; McCrory; McBroom; Sanders
Published in: Comparative Effectiveness Research
January 2013
Duke Scholars
Published In
Comparative Effectiveness Research
DOI
EISSN
1179-8483
Publication Date
January 2013
Start / End Page
1 / 1
Publisher
Informa UK Limited
Citation
APA
Chicago
ICMJE
MLA
NLM
Crowley, M., Powers, Myers, McCrory, McBroom, & Sanders. (2013). Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states? Comparative Effectiveness Research, 1–1. https://doi.org/10.2147/cer.s39610
Crowley, Matthew, Powers, Myers, McCrory, McBroom, and Sanders. “Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states?” Comparative Effectiveness Research, January 2013, 1–1. https://doi.org/10.2147/cer.s39610.
Crowley M, Powers, Myers, McCrory, McBroom, Sanders. Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states? Comparative Effectiveness Research. 2013 Jan;1–1.
Crowley, Matthew, et al. “Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states?” Comparative Effectiveness Research, Informa UK Limited, Jan. 2013, pp. 1–1. Crossref, doi:10.2147/cer.s39610.
Crowley M, Powers, Myers, McCrory, McBroom, Sanders. Angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers: do future research needs differ across disease states? Comparative Effectiveness Research. Informa UK Limited; 2013 Jan;1–1.
Published In
Comparative Effectiveness Research
DOI
EISSN
1179-8483
Publication Date
January 2013
Start / End Page
1 / 1
Publisher
Informa UK Limited